Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Jade Biosciences, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +6 vs. Q3 2021
- Shares held
- 25.6M
- +3.93M (+18.1%) vs. Q3 2021
- Total value
- $301.6M
- −$151.0M (−33.4%) vs. Q3 2021
- New holders
- 12
- 16 more added
- Sold out
- 6
- 9 more reduced
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 484 | $6.00K | 0.00% | −607−55.6% | Reduced |
| Ameritas Investment Partners, Inc. | 772 | $9.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 941 | $11.0K | 0.00% | 00.0% | Unchanged |
| Allspring Global Investments Holdings, LLC | 1,097 | $12.0K | 0.00% | +1,097 | New |
| Royal Bank of Canada | 2,263 | $26.0K | 0.00% | +1,009+80.5% | Added |
| STRS Ohio | 2,300 | $27.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 3,124 | $37.0K | 0.00% | +2,710+654.6% | Added |
| Citigroup Inc | 3,468 | $41.0K | 0.00% | +2,319+201.8% | Added |
| Wells Fargo & Company | 4,470 | $52.0K | 0.00% | +4,415+8,027.3% | Added |
| New York State Common Retirement Fund | 4,770 | $56.0K | 0.00% | +2,970+165.0% | Added |
| American International Group, Inc. | 5,354 | $63.0K | 0.00% | −161−2.9% | Reduced |
| California State Teachers Retirement System | 5,922 | $70.0K | 0.00% | +477+8.8% | Added |
| JPMorgan Chase & Co | 6,012 | $71.0K | 0.00% | +770+14.7% | Added |
| Deutsche Bank AG | 6,106 | $72.0K | 0.00% | +312+5.4% | Added |
| Morgan Stanley | 7,951 | $94.0K | 0.00% | +5,210+190.1% | Added |
| Bank of America Corp | 9,515 | $112.0K | 0.00% | +8,634+980.0% | Added |
| Chicago Partners Investment Group LLC | 14,849 | $140.0K | 0.01% | −1,227−7.6% | Reduced |
| Jane Street Group, LLC | 12,415 | $146.0K | 0.00% | +12,415 | New |
| Old Well Partners, LLC | 12,600 | $149.0K | 0.09% | 00.0% | Unchanged |
| Squarepoint Ops LLC | 12,941 | $153.0K | 0.00% | +12,941 | New |
| Nuveen Asset Management, LLC | 14,318 | $157.0K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 15,769 | $186.0K | 0.00% | +15,769 | New |
| Golden State Equity Partners | 15,930 | $188.0K | 0.09% | +15,930 | New |
| Goldman Sachs Group Inc | 18,763 | $221.0K | 0.00% | +18,763 | New |
| Bank of New York Mellon Corp | 23,813 | $281.0K | 0.00% | +2,022+9.3% | Added |
| Charles Schwab Investment Management Inc | 24,736 | $292.0K | 0.00% | 00.0% | Unchanged |
| HRT Financial LP | 34,854 | $410.0K | 0.00% | +34,854 | New |
| Parametric Portfolio Associates LLC | 36,000 | $424.0K | 0.00% | −105,638−74.6% | Reduced |
| Parkwood LLC | 37,156 | $438.0K | 0.08% | −10,903−22.7% | Reduced |
| Northern Trust Corp | 87,169 | $1.03M | 0.00% | −1,036−1.2% | Reduced |
| Norges Bank | 101,505 | $1.20M | 0.00% | +101,505 | New |
| State Street Corp | 154,224 | $1.82M | 0.00% | +28,381+22.6% | Added |
| Geode Capital Management, LLC | 157,730 | $1.86M | 0.00% | +43,307+37.8% | Added |
| Fred Alger Management, LLC | 167,007 | $1.97M | 0.00% | +167,007 | New |
| Sectoral Asset Management Inc | 282,764 | $3.33M | 0.50% | −58,603−17.2% | Reduced |
| Vanguard Group Inc | 468,315 | $5.52M | 0.00% | −313,060−40.1% | Reduced |
| OrbiMed Advisors LLC | 535,714 | $6.32M | 0.08% | 00.0% | Unchanged |
| OUP Management Co., LLC | 603,762 | $7.12M | 3.21% | +603,762 | New |
| FMR LLC | 718,351 | $8.47M | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 729,808 | $8.61M | 0.00% | +246,790+51.1% | Added |
| TCG Crossover Management, LLC | 853,330 | $10.1M | 4.71% | +853,330 | New |
| Citadel Advisors LLC | 1,597,479 | $18.8M | 0.02% | +2,666+0.2% | Added |
| Cormorant Asset Management, LP | 1,830,691 | $21.6M | 1.28% | −200,000−9.8% | Reduced |
| Baker Bros. Advisors LP | 1,831,789 | $21.6M | 0.11% | +179,618+10.9% | Added |
| Atlas Venture Life Science Advisors, LLC | 3,103,879 | $36.6M | 3.36% | +3,103,879 | New |
| Sofinnova Investments, Inc. | 3,758,686 | $44.3M | 2.84% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 8,263,982 | $97.4M | 1.72% | 00.0% | Unchanged |
| Deerfield Management Company, L.P. (Series C) | 0 | $0 | 0.00% | −714,285−100.0% | Sold out |
| Millennium Management LLC | 0 | $0 | 0.00% | −69,867−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −53,872−100.0% | Sold out |
| Darwin Global Management, Ltd. | 0 | $0 | 0.00% | −12,484−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −775−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −285−100.0% | Sold out |